Tarhini, A. A., Leng, S., Moschos, S. J., Yin, Y., Sander, C., Lin, Y., . . . Kirkwood, J. M. (2012). Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in-adjuvant with PF-3512676 and GM-CSF in metastatic melanoma.

Tarhini, Ahmad A., Siyang Leng, Stergios J. Moschos, Yan Yin, Cindy Sander, Yan Lin, William E. Gooding, a John M. Kirkwood. Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), Gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In-adjuvant With PF-3512676 and GM-CSF in Metastatic Melanoma. 2012.

Tarhini, Ahmad A., et al. Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), Gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In-adjuvant With PF-3512676 and GM-CSF in Metastatic Melanoma. 2012.